Lamivudine + Zidovudine + Nevirapine Tablet manufacturer supplier exporter

Lamivudine Tablets IP 100 mg
Each Filmcoated tablet contains :
Lamivudine IP 100 mg exceipents Q.S.

Lamivudine Tablets IP 150 mg
Each Filmcoated tablet contains :
Lamivudine IP 150 mg

Lamivudine 150 mg + Zidovudine 300 mg + Nevirapine 200 mg tablets IP Each Film Coated Tablets Contains: Lamivudine IP 150 mg Zidovudine IP 300 mg Nevirapine IP 200 mg Excipients Q.S.

Lamuzy Tablets Lamivudine and Zidovudine Tablets IP
Each Film Coated tablet contains :
Zidovudine IP 300 mg
Lamivudine IP 150 mg

Cirolam 150 Tablets
Lamivudine Tablets 150 mg
Each Film Coated tablet contains :
Lamivudine USP 150 mg

Usage: – Hepatitis B infection

Category: – HIV Anti Viral drugs

Therapeutic category: – Antiviral, Anti HIV, Hepatitis Treatment

Description

Lamivudine + Zidovudine + Nevirapine tablet

Healthy Incorporation and Healthy life pharma Pvt ltd are one of the leading manufacturer, supplier, and exporter of Lamivudine tablets 100 mg, Zidovudine 300 mg in India and serving the world with best quality pharmaceutical products.

Lamivudine + Zidovudine + Nevirapine tablet Manufacturer

Healthy incorporation and Healthy life pharma Pvt ltd, is Mumbai Based WHO GMP certified manufacturer of injection, tablets, capsules, liquid, dry syrups, pre-filled syringes, ointments etc. with an extensive experience of over 45 years in manufacturing and have reach in many countries. We are committed to provide a stock of highly effective Lamivudine tablets to our innumerable clients with the help of our well-experienced pharmaceutical specialists. We supply this tablets in different strength & combination.

Lamivudine 150 mg + Zidovudine 300 mg + Nevirapine 200 mg tablets
Lamivudine 150 mg + Zidovudine 300 mg tablets
Uses of Lamivudine tablets :
Lamivudine does not completely treat HIV infection; it decreases the amount of virus in your body and maintain it at a low level. It also boosts the CD4 cell count in your blood. These are the cells type of white blood cells which are important in body to fight any infection. Responds to treatment with Lamivudine is not same for all. Your doctor will observe the effectiveness of your treatment. Although this drug does not cure HIV, it may reduce your chance of developing acquired immunodeficiency syndrome (AIDS) and HIV-related illnesses such as serious infections or cancer. Use an effective protection method like latex or polyurethane condoms/dental dams during sexual inter course. It is advisable to not share any personal items like needles/syringes, toothbrushes, and razors that may have contacted blood or other body fluids with anyone.

Additional Information of Lamivudine + Zidovudine + Nevirapine tablet :

Product Name Lamivudine tablets

Composition & Active ingredients Lamivudine 100 mg,150 mg, Lamivudine 150 mg+Zidovudine 300 mg + Nevirapine 200 mg

Potency Lamivudine 150 mg + Zidovudine 300 mg

Therapeutic use Hepatitis B infection

Packing 10 Tablets (1 Box)

Dosage As per Doctor Prescription

Please inform doctor your medical history of have ever had hepatitis C virus infection or other liver disease, kidney disease, or pancreas disease, diabetes. Consult your doctor if you are pregnant or planning to get pregnant, or breast- feeding mother.

Side Effects of Lamivudine tablets:
Most of the time there is no serious side effects. Some common side effects may arise after starting medication, as your body adjust to medicine. If any of your symptoms worsen then consult your doctor immediately

Tiredness
Fever
Muscle pain & discomfort
Joint pain
Insomnia
Diarrhea
Constipation
Insomnia
Headache
Dizziness /Drowsiness
Cough
Nausea
Vomiting
Rash
Hairloss
For Detailed Product Information Contact Us at +91 7710003340, If you need Any assistance in selecting our Products that fits your requirements. If you’re looking for any product that you’re not seeing here, please contact our support team.

Lamivudine + Zidovudine + Nevirapine tablets

Here’s a brief overview of each of these drugs:

Lamivudine (also known as 3TC): Lamivudine is a nucleoside reverse transcriptase inhibitor (NRTI). It works by inhibiting the reverse transcriptase enzyme, which is essential for the replication of HIV.

Zidovudine (also known as AZT): Zidovudine is another NRTI. Like Lamivudine, it also inhibits the reverse transcriptase enzyme.

Nevirapine: Nevirapine is a non-nucleoside reverse transcriptase inhibitor (NNRTI). It works by binding to and inhibiting the reverse transcriptase enzyme, disrupting the replication of HIV.

Combination therapy with these drugs, often referred to as Highly Active Antiretroviral Therapy (HAART), is the standard approach in managing HIV. The specific combination, dosage, and timing of these drugs may vary depending on individual patient factors, such as the stage of HIV infection, drug resistance, and other health considerations. It’s essential for individuals with HIV to work closely with their healthcare providers to determine the most suitable treatment plan for their unique needs. Additionally, it’s important to adhere to the prescribed regimen to effectively manage the virus and maintain good health.

Lamivudine: Lamivudine is a nucleoside reverse transcriptase inhibitor (NRTI) that inhibits the replication of HIV by interfering with the virus’s ability to copy its genetic material.

Zidovudine: Zidovudine, also known as AZT (azidothymidine), is another NRTI. It works similarly to lamivudine, inhibiting HIV replication by blocking the reverse transcriptase enzyme.

Nevirapine: Nevirapine is a non-nucleoside reverse transcriptase inhibitor (NNRTI). It acts on a different target within the virus, the reverse transcriptase enzyme, to inhibit viral replication.

The specific combination of drugs and dosage may vary depending on the patient’s individual needs, the stage of their infection, and other factors. It’s essential for individuals living with HIV to take their prescribed medications as directed by their healthcare provider to effectively manage the virus and maintain their health.

Please note that medical guidance on HIV treatment can change over time, so it’s crucial for individuals with HIV to consult their healthcare provider for the most up-to-date information and personalized treatment plans.

Lamivudine, zidovudine, and nevirapine are three antiretroviral medications commonly used to treat HIV (Human Immunodeficiency Virus) infection. They are often prescribed in combination as part of highly active antiretroviral therapy (HAART) to help control the virus and slow the progression of HIV/AIDS.

Lamivudine: Lamivudine is a nucleoside reverse transcriptase inhibitor (NRTI) that works by blocking the reverse transcriptase enzyme, which is essential for the replication of HIV. It is often used in combination with other antiretroviral drugs to prevent the virus from multiplying.

Zidovudine (AZT): Zidovudine is another NRTI that also inhibits the reverse transcriptase enzyme. It was one of the first drugs approved for the treatment of HIV/AIDS and is often used in combination with other medications to reduce the viral load and improve immune function.

Nevirapine: Nevirapine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that works differently from NRTIs. It also inhibits the reverse transcriptase enzyme, but it does so by binding to a different site on the enzyme. This helps to prevent the virus from replicating and spreading in the body.

Combining these three drugs can provide an effective treatment regimen for HIV, as it attacks the virus from multiple angles, making it more difficult for the virus to develop resistance. However, the specific combination and dosage of these medications would be determined by a healthcare provider based on the individual patient’s medical history, viral load, and other factors.

It’s important to note that HIV treatment should be taken under the guidance of a healthcare professional, and patients should follow their prescribed regimen closely to ensure the best outcomes and minimize the risk of developing drug resistance. Additionally, like all medications, these drugs can have potential side effects and interactions, so regular monitoring and follow-up with a healthcare provider are crucial for the management of HIV infection.

Lamivudine, Zidovudine, and Nevirapine are antiretroviral medications commonly used to treat HIV (Human Immunodeficiency Virus) infection. These drugs work in different ways to combat the virus and are often prescribed together as part of a combination therapy to effectively control HIV replication and slow the progression of the disease.

Here’s a brief overview of each of these drugs:

Lamivudine: Lamivudine is a nucleoside reverse transcriptase inhibitor (NRTI) that inhibits the reverse transcriptase enzyme necessary for HIV replication. It is commonly used in combination therapy for HIV and is well-tolerated by most patients.

Zidovudine: Zidovudine (also known as AZT) is another NRTI. It works by interfering with the HIV virus’s ability to replicate its genetic material. Zidovudine was one of the first drugs approved for the treatment of HIV, and it’s often used in combination with other antiretroviral drugs.

Nevirapine: Nevirapine is a non-nucleoside reverse transcriptase inhibitor (NNRTI). It works by binding to and inhibiting the reverse transcriptase enzyme, preventing HIV from making copies of itself. Nevirapine is often used in combination with NRTIs and other antiretroviral drugs to enhance the effectiveness of HIV treatment.

The combination of Lamivudine, Zidovudine, and Nevirapine is a well-established treatment regimen for HIV. This combination is sometimes referred to as “3TC/AZT/NVP” or “Combivir + Nevirapine.” It’s important to note that the specific choice of antiretroviral therapy can vary depending on an individual’s medical history, HIV strain, drug resistance, and other factors. The choice of medications should be made by a healthcare provider experienced in HIV treatment.

It’s crucial for individuals taking these medications to follow their prescribed regimen diligently and attend regular medical check-ups to monitor the effectiveness of treatment and address any side effects or complications. HIV therapy has advanced significantly over the years, and with proper adherence, many people with HIV can lead healthy and fulfilling lives.

Lamivudine, Zidovudine, and Nevirapine are medications commonly used in the treatment of HIV/AIDS. These three drugs are often prescribed together as part of combination antiretroviral therapy (ART) to manage the HIV infection. Here’s some information about each of these drugs:

Lamivudine:

Lamivudine is an antiretroviral medication that belongs to the nucleoside reverse transcriptase inhibitor (NRTI) class.

It works by inhibiting the reverse transcriptase enzyme, which is essential for HIV replication.

Lamivudine is often used in combination with other antiretroviral drugs to reduce HIV viral load and slow the progression of the disease.

It is available in tablet form and is typically taken once daily.

Zidovudine (also known as AZT):

Zidovudine is another NRTI antiretroviral medication.

It also inhibits the reverse transcriptase enzyme in HIV.

Zidovudine is used in combination with other antiretroviral drugs to reduce viral replication and improve the immune system’s function.

It is available in tablet form and is taken multiple times a day, usually every 4 to 6 hours.

Nevirapine:

Nevirapine is a non-nucleoside reverse transcriptase inhibitor (NNRTI).

It works by binding to and inhibiting the reverse transcriptase enzyme, preventing HIV from replicating.

Nevirapine is used in combination with other antiretroviral medications to suppress HIV viral load and enhance the immune system.

It is available in tablet form and is typically taken once or twice daily.

It’s important to note that the combination of these drugs should be prescribed and administered under the guidance of a healthcare professional who specializes in HIV treatment. The specific dosages and regimen may vary based on an individual’s medical history, the stage of their HIV infection, and other factors.

Adherence to the prescribed treatment plan is crucial for the effectiveness of antiretroviral therapy, and individuals taking these medications should follow their healthcare provider’s instructions carefully. Additionally, regular monitoring and follow-up with a healthcare provider are essential to assess the response to treatment and manage potential side effects.

Lamivudine, Zidovudine, and Nevirapine are antiretroviral medications commonly used in the treatment of HIV (human immunodeficiency virus) infection. They are often combined in a single tablet or as part of an HIV treatment regimen. Here’s a brief overview of each of these drugs:

Lamivudine (also known as 3TC):

Lamivudine is a nucleoside reverse transcriptase inhibitor (NRTI).

It works by inhibiting the reverse transcriptase enzyme, which HIV uses to replicate itself.

Zidovudine (also known as AZT):

Zidovudine is another nucleoside reverse transcriptase inhibitor (NRTI).

Nevirapine:

Nevirapine is a non-nucleoside reverse transcriptase inhibitor (NNRTI).

It also inhibits the reverse transcriptase enzyme but through a different mechanism compared to NRTIs.

 

Combining these three medications into a single tablet can simplify the dosing regimen for people with HIV, making it easier to adhere to their treatment plan. However, the specific formulation of this combination may vary by manufacturer and region. It’s crucial for individuals with HIV to follow their healthcare provider’s recommendations regarding medication, dosing, and any potential side effects. Additionally, new HIV treatment guidelines and medications may have emerged since my last knowledge update in September 2021, so it’s important to consult with a healthcare professional for the most up-to-date information.